Evidence map›Paper›PMID 34487313›Full record

Trial reportJournal of neuro-oncology2021

eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial.

Sophie D van der Linden, Geert-Jan M Rutten, Linda Dirven, Martin J B Taphoorn, Djaina D Satoer, Clemens M F Dirven, Margriet M Sitskoorn, Karin Gehring

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 6 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 6 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Methodology of analysis of cognitive impairment in longitudinal randomized clinical trials in oncology: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Treatment Options for IDH-Mutant Malignant Gliomas.Current treatment options in oncology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sophie D van der LindenDepartment of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Geert-Jan M RuttenDepartment of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Linda DirvenDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Martin J B TaphoornDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Djaina D SatoerDepartment of Neurosurgery, Erasmus Medical Center, Rotterdam, the Netherlands.
Clemens M F DirvenDepartment of Neurosurgery, Erasmus Medical Center, Rotterdam, the Netherlands.
Margriet M SitskoornDepartment of Cognitive Neuropsychology, Tilburg University, Room S219, P.O. Box 90153, 5000 LE, Tilburg, the Netherlands.
Karin GehringDepartment of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands. k.gehring@uvt.nl.ORCID http://orcid.org/0000-0002-6989-1855
Tilburg University · NLErasmus MC · NLLeiden University Medical Center · NLElisabeth-TweeSteden Ziekenhuis · NL

Funding

ZonMw 842003009
6 · The paper itself

Abstract

backgroundEvidence-based cognitive rehabilitation programs for brain tumor patients are not widely available, despite the high need. We aimed to evaluate the effects of a tablet-based cognitive rehabilitation program on cognitive performance, cognitive complaints, fatigue, and psychological distress in primary brain tumor patients following neurosurgery. Also, attrition, adherence and patient satisfaction with the program were evaluated.

methodsAdults with presumed low-grade glioma and meningioma were recruited before surgery. Three months thereafter, participants were allocated to the intervention group or waiting-list control group using minimization. The 10-week eHealth app ReMind, based on the effective face-to-face intervention, consisted of psychoeducation, strategy-training and attention retraining. Performance-based cognitive outcomes and patient-reported outcomes were assessed before surgery and 3, 6 and 12 months thereafter. Mean scores, percentages of cognitively impaired individuals and reliable change indices (RCIs) were compared between groups.

resultsSixty-two out of 183 eligible patients were randomized. Of the people who declined, 56% reported that participation would to be too burdensome. All participants found a tablet-app suitable for delivery of cognitive rehabilitation and 90% rated the program as "good" or "excellent". Performance-based cognitive outcomes and patient-reported outcomes did not significantly differ in group means over time nor RCIs between the intervention (final n = 20) and control group (final n = 25).

conclusionsRecruitment at this early stage was difficult, resulting in limited statistical power. No significant effects were demonstrated, while adherence and satisfaction with the eHealth program were good. In clinical practice, ReMind may be helpful, if timing would be adapted to patients' needs.

Indexed as

Brain NeoplasmsCognitionGliomaHumansMeningeal NeoplasmsTelemedicineCognitive rehabilitationeHealthGliomaMeningiomaNeurosurgeryRandomized controlled trial

Identifiers

PMID34487313
PMCPMC8484142
OpenAlexW3197456500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.